twins linus, left, and maarten have more sweat glands and tooth precursors than their older brother joshua, 5, after being treated with a drug in utero..
photos
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital...
.- mar - ?????
.